Insulin detemir reduces weight gain as a result of reduced food intake in patients with type 1 diabetes.
about
Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake?Observational 6-month open-label study of Japanese type 2 diabetes patients switching from NPH insulin to insulin detemir in basal-bolus regimen: 23rd article of the Japan Diabetes Clinical Data Management Study Group (JDDM23).Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis.Effects of insulin detemir and NPH insulin on body weight and appetite-regulating brain regions in human type 1 diabetes: a randomized controlled trial.Insulin Detemir Is Transported From Blood to Cerebrospinal Fluid and Has Prolonged Central Anorectic Action Relative to NPH Insulin.Insulin degludec/insulin aspart administered once daily at any meal, with insulin aspart at other meals versus a standard basal-bolus regimen in patients with type 1 diabetes: a 26-week, phase 3, randomized, open-label, treat-to-target trial.Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureasCerebral blood flow and glucose metabolism in appetite-related brain regions in type 1 diabetic patients after treatment with insulin detemir and NPH insulin: a randomized controlled crossover trial.Insulin detemir: a review of its use in the management of diabetes mellitus.A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review.Hepatoselectivity and the evolution of insulin.The endocrinology of food intake.PEGylated insulin Lispro, (LY2605541)--a new basal insulin analogue.Physical activity and type 1 diabetes: time for a rewire?Central Effects of Insulin Detemir on Feeding, Body Weight and Metabolism in Rats.Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomesMetformin as add-on to intensive insulin therapy in type 1 diabetes mellitus.Using the cerebrospinal fluid to understand ingestive behavior.Medication use for the treatment of diabetes in obese individuals.The comparison of 24-hour urinary sodium, albumin, and protein excretion in chronic kidney disease patients with type 2 diabetes mellitus using insulin detemir or insulin glargine.The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus.Weight-neutral effect of once-daily insulin detemir in Chinese type 2 diabetes patients: subgroup analysis of the SOLVE study.Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir.Effect of subcutaneous insulin detemir on glucose flux, lipolysis and electroencephalography in type 1 diabetes.Efficacy of laparoscopic sleeve gastrectomy and intensive medical management in obese patients with type 2 diabetes mellitus.
P2860
Q27026774-8D9E3032-72A9-4BA9-B41D-1084C0F02A4CQ34276309-D15B7667-1FA3-4855-82F7-555F3247A316Q34349437-782911BB-4284-4E77-8D40-6F03EF5E8BEDQ35150366-05E95263-2C1A-4F2D-8FFA-DD97616099D7Q35769593-B5C5F698-52AF-4CD1-80F6-409FBCF84FFFQ36334638-E6E59746-378F-4196-8F86-3DC390B72331Q36782811-660122CB-47FA-44E1-BE89-DE86962CB763Q37331162-E64736DA-2583-4499-9AC2-065C57FBA99FQ38056540-88BC12AB-D837-48BC-8034-F8603A80547FQ38095682-4515DDFF-90C8-4AEF-A8F5-BC9CFC4F5398Q38107244-FF5F2B05-BFA9-4613-841B-4DD0BC2EC9D0Q38123372-617C494A-88BB-4409-A7ED-4B573B4D7A20Q38128590-4BCA82CC-06D6-46A6-A705-1474C4E98A28Q38310888-B8F23859-749B-4FEB-8056-5DDAAC4AA0E3Q38673291-DC25781B-E5F0-46FD-BE1B-1F9627B2387EQ38824504-CC54412C-22C4-406A-901D-E70AF36272D1Q38894618-342435BD-3458-4F76-BCCE-2499091EFE9EQ39030948-3D3903E8-F474-4BA0-ACDE-FEB37C449DE0Q39304674-0B1EEEB3-D653-4B4E-AD98-E45A642C3B12Q45050904-EA70D544-AB7E-45AF-AF4D-C012EBC2DEE3Q47109935-FE84C345-4D7F-4FE4-AD78-74EB585A7B45Q47582929-30B94673-6BBC-4214-95FC-CECB389BE2A4Q47745734-CA86605E-CF38-424E-B09E-D2E7B2296706Q47947014-93EE3BB9-C508-4163-BA31-FB55FD30A43CQ48129687-7387227E-2328-4DD7-B216-ED838FE3AAAA
P2860
Insulin detemir reduces weight gain as a result of reduced food intake in patients with type 1 diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Insulin detemir reduces weight ...... patients with type 1 diabetes.
@ast
Insulin detemir reduces weight ...... patients with type 1 diabetes.
@en
type
label
Insulin detemir reduces weight ...... patients with type 1 diabetes.
@ast
Insulin detemir reduces weight ...... patients with type 1 diabetes.
@en
prefLabel
Insulin detemir reduces weight ...... patients with type 1 diabetes.
@ast
Insulin detemir reduces weight ...... patients with type 1 diabetes.
@en
P2093
P2860
P921
P356
P1433
P1476
Insulin detemir reduces weight ...... patients with type 1 diabetes.
@en
P2093
A Margot Umpleby
Ben Sheldon
David L Russell-Jones
Fariba Shojaee-Moradie
Katharine Backhouse
Nicola C Jackson
Richard H Jones
Sigurd Johnsen
Sunil Zachariah
P2860
P304
P356
10.2337/DC11-0098
P407
P577
2011-05-18T00:00:00Z